These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 38105925)

  • 1. Immunology of amyotrophic lateral sclerosis - role of the innate and adaptive immunity.
    Mimic S; Aru B; Pehlivanoğlu C; Sleiman H; Andjus PR; Yanıkkaya Demirel G
    Front Neurosci; 2023; 17():1277399. PubMed ID: 38105925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.
    Malaspina A; Puentes F; Amor S
    Int Immunol; 2015 Mar; 27(3):117-29. PubMed ID: 25344935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
    Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
    Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis.
    Kjældgaard AL; Pilely K; Olsen KS; Pedersen SW; Lauritsen AØ; Møller K; Garred P
    Mol Immunol; 2018 Oct; 102():14-25. PubMed ID: 29933890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
    Zhao W; Beers DR; Appel SH
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):888-99. PubMed ID: 23881705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia.
    Motataianu A; Barcutean L; Balasa R
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):159-166. PubMed ID: 31903792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Innate Immune System in ALS.
    Phani S; Re DB; Przedborski S
    Front Pharmacol; 2012; 3():150. PubMed ID: 22912616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications.
    Calma AD; Pavey N; Menon P; Vucic OS
    Curr Opin Neurol; 2024 May; ():. PubMed ID: 38775138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS).
    Kaur K; Chen PC; Ko MW; Mei A; Chovatiya N; Huerta-Yepez S; Ni W; Mackay S; Zhou J; Maharaj D; Malarkannan S; Jewett A
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis.
    Chiarotto GB; Nardo G; Trolese MC; França MC; Bendotti C; Rodrigues de Oliveira AL
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Immune Activation by
    Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
    Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.
    Liu J; Wang F
    Front Immunol; 2017; 8():1005. PubMed ID: 28871262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
    Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
    Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.
    You J; Youssef MMM; Santos JR; Lee J; Park J
    Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual roles of immunity in ALS: injury overrides protection.
    Murdock BJ; Bender DE; Segal BM; Feldman EL
    Neurobiol Dis; 2015 May; 77():1-12. PubMed ID: 25726748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity in amyotrophic lateral sclerosis.
    Moisse K; Strong MJ
    Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils: a subgroup of neglected immune cells in ALS.
    Cao W; Fan D
    Front Immunol; 2023; 14():1246768. PubMed ID: 37662922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Innate Immunity and Inflammasomes Involved in Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)?
    Volpe CM; Nogueira-Machado JA
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(1):40-5. PubMed ID: 25845840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroinflammation in amyotrophic lateral sclerosis].
    Endo F; Yamanaka K
    Rinsho Shinkeigaku; 2014; 54(12):1128-31. PubMed ID: 25672727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.